STXS · AMEX
Stereotaxis (STXS) Stock Price & Fundamentals
Stereotaxis (STXS) closed at $396.79 on Oct 9, 2026, up 0.10% from the previous close of $396.38.
Share price, past year
1Y +11.13%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $396.79 |
| Sep 30, 2026 | $378.16 |
| Aug 31, 2026 | $388.15 |
| Jul 31, 2026 | $413.83 |
| Jun 30, 2026 | $413.71 |
| May 29, 2026 | $412.73 |
| Apr 30, 2026 | $385.29 |
| Mar 31, 2026 | $363.36 |
| Feb 27, 2026 | $386.05 |
| Jan 30, 2026 | $371.08 |
| Dec 31, 2025 | $347.84 |
| Nov 28, 2025 | $339.94 |
| Oct 31, 2025 | $358.90 |
Key statistics
- Market cap
- $39.76B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.24
- Revenue (TTM)
- $30.07M
- Net income (TTM)
- −$22.32M
- Shares outstanding
- 100.2M
- Dividend yield
- —
- 52-week range
- $336.50 – $432.74
Stereotaxis's market cap is $39.76B, based on a share price of $396.79 and 100.2M shares outstanding as of Jul 31, 2026.
Financials
Stereotaxis reported revenue of $32.38M for fiscal 2025, up 20.28% from fiscal 2024.
Stereotaxis reported a net loss of $21.64M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $32.38M | +20.3% | −$21.64M | −66.9% | −$0.25 | — |
| FY2024ended Dec 31, 2024 | $26.92M | +0.6% | −$24.05M | −89.3% | −$0.30 | — |
| FY2023ended Dec 31, 2023 | $26.77M | −4.9% | −$20.71M | −77.4% | −$0.27 | — |
| FY2022ended Dec 31, 2022 | $28.15M | −19.6% | −$18.29M | −65.0% | −$0.26 | — |
| FY2021ended Dec 31, 2021 | $35.02M | +31.5% | −$10.72M | −30.6% | −$0.16 | — |
| FY2020ended Dec 31, 2020 | $26.63M | −7.9% | −$6.65M | −25.0% | −$0.11 | — |
| FY2019ended Dec 31, 2019 | $28.90M | −1.5% | −$4.59M | −15.9% | −$0.10 | — |
| FY2018ended Dec 31, 2018 | $29.35M | −5.8% | $116.76K | 0.4% | −$0.03 | — |
| FY2017ended Dec 31, 2017 | $31.14M | −3.2% | −$5.89M | −18.9% | −$0.32 | — |
| FY2016ended Dec 31, 2016 | $32.16M | — | −$5.29M | −16.4% | −$0.54 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $7.67M | −$4.47M | −$0.05 |
| Q1 FY2026ended Mar 31, 2026 | $6.29M | −$5.86M | −$0.06 |
| Q4 FY2025ended Dec 31, 2025 | $8.64M | −$5.53M | −$0.06 |
| Q3 FY2025ended Sep 30, 2025 | $7.46M | −$6.46M | −$0.07 |
| Q2 FY2025ended Jun 30, 2025 | $8.80M | −$3.83M | −$0.05 |
| Q1 FY2025ended Mar 31, 2025 | $7.47M | −$5.82M | −$0.07 |
| Q4 FY2024ended Dec 31, 2024 | $6.34M | −$7.52M | −$0.09 |
| Q3 FY2024ended Sep 30, 2024 | $9.20M | −$6.19M | −$0.08 |
Company profile
- Name
- Stereotaxis, Inc.
- Ticker
- STXS
- Exchange
- AMEX
- Industry (SEC SIC)
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- 710 N Tucker Blvd, Ste 110, St.Louis, MO 63101
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001289340
Recent SEC filings
- Aug 12, 2026
- Aug 11, 2026
- Jul 16, 2026
- Jul 9, 2026
- May 15, 2026
- May 13, 2026
- May 12, 2026
- Apr 15, 2026
Frequently asked questions
What is Stereotaxis's stock price?
Stereotaxis (STXS) closed at $396.79 on Oct 9, 2026, up 0.10% from the previous close of $396.38.
What is Stereotaxis's market cap?
Stereotaxis's market cap is $39.76B, based on a share price of $396.79 and 100.2M shares outstanding as of Jul 31, 2026.
How much revenue does Stereotaxis make?
Stereotaxis reported revenue of $32.38M for fiscal 2025, up 20.28% from fiscal 2024.
Does Stereotaxis pay a dividend?
Stereotaxis's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Stereotaxis, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures